News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Volastra Therapeutics Commences First Patient Treatment in Phase I/II Clinical Study of VLS-1488, Part of Their Unique Range of KIF18A Inhibitors
Tuesday, October 31, 2023Volastra Therapeutics a biotechnology company specializing in cancer research has announced the commencement of the first patients dosing in a Phase III clinical trial evaluating VLS VLS in combination
Merck KGaA, Darmstadt, Germany, Strengthens Oncology Pipeline with Hengrui Partnership
Monday, October 30, 2023Merck KGaA Darmstadt Germany a prominent science and technology company has announced a strategic partnership with Jiangsu Hengrui Pharmaceuticals Co Ltd This collaboration involves an exclusive global
First Clinical Results of ATA-100, a Gene Therapy for Treating Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9), Shared at ESGCT
Saturday, October 28, 2023Atamyo Therapeutics a biotechnology company dedicated to advancing newgeneration gene therapies for the treatment of muscular dystrophies and cardiomyopathies has today unveiled the initial clinical
IDP Pharma Commences Phase 1/2 Clinical Trial for IDP-121, a Novel Direct cMyc Protein Inhibitor and Degrader
Friday, October 27, 2023IDP Pharma a clinicalstage biotechnology company is pioneering the development of drugs that directly target and degrade intrinsically disordered proteins IDPs They have announced the successful dosing
TC BioPharm Partners with Excellos as CDMO to Meet Expanding US Clinical Trial Demands
Thursday, October 26, 2023TC BioPharm has revealed its partnership with Excellos a Contract Development Manufacturing Organization based in San Diego California Excellos which originated from the San Diego Blood Bank
AGC Biologics and Medigene Collaborate on TCR-T Cell Services Agreement to Advance New Cell Therapy Products
Thursday, October 26, 2023AGC Biologics a prominent biopharmaceutical development and contract manufacturing organization has recently entered into a new service agreement with Medigene
Endogena Therapeutics Receives FDA Authorization for Innovative Treatment Targeting AMD
Wednesday, October 25, 2023Endogena Therapeutics Inc a pioneering biotechnology company dedicated to advancing regenerative medicine is excited to announce a significant achievement with the potential to transform lives The US Food and Drug Administration
The FDA Grants Approval for a Novel Therapy Targeting Rare Blood Cancers Known as Myelodysplastic Syndromes
Wednesday, October 25, 2023Today the US Food and Drug Administration has granted its approval to Tibsovo for the treatment of adult patients with relapsed or refractory RR myelodysplastic syndromes who carry an isocitrate dehydrogenase
Genialis and Cancer Research Horizons Collaborate to Develop AI-Enhanced Patient Classification Tools for Cancer Research
Tuesday, October 24, 2023Genialis a company specializing in RNAbased biomarkers has announced a collaborative datasharing initiative with Cancer Research Horizons the innovation division of Cancer Research UK
Alaya.bio Expands Its in Vivo CAR-T Immunotherapy Platform by Acquiring Vital Assets From Ixaka France
Saturday, October 21, 2023Alayabio a biotechnology company specializing in in vivo gene delivery has recently completed the acquisition of all assets previously held by Ixaka France Ixaka was a preclinicalstage immunotherapy biotech firm focused on in vivo CAR Tcell therapy
